FDA revokes approval of drug for breast cancer
Thousands of women with advanced breast cancer who are being treated with the drug Avastin may be taken off the drug after the US Food and Drug Adminimstration announced today that is revoking the medication’s approval for treatment of breast cancer. The FDA commissioner, Dr. Margaret A. Hamburg, said she based her decision on studies concluding that the drug has not been shown to be safe or life-extending for women with breast cancer that has spread.
For more from BostonGlobe.com, sign up or log in below
To continue, please sign up or log in to BostonGlobe.com
Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com
Sign up
Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.
Are you a Boston Globe home delivery subscriber?
Get FREE access as part of your print subscription.
BostonGlobe.com subscriber
Click to continue reading this article or to log in to BostonGlobe.com.
